The activity of IF1 as an inhibitor of the ATP synthase is regulated by matrix pH under conditions of mitochondrial de-energization (13, 23–25) and by the phosphorylation of S39 under several physiological situations such as progression through the cell cycle, hypoxia, rapid changes in metabolic demand, and cancer (26). The gene discussed is ATP5IF1; the disease is cancer.